MAPT and tauopathy: On the contrary, in pure tauopathy mouse models, TREM2 KO mice exhibit markedly reduced tau pathology, accompanied by decreased microglial density and downregulation of neuroinflammatory genes, suggesting that TREM2 deficiency may mitigate tau propagation by suppressing microglial activation or inflammatory signaling pathways [158].